Literature DB >> 16466819

Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review.

Stephen Mangar1, Nicholas Slevin, Kathleen Mais, Andrew Sykes.   

Abstract

BACKGROUND AND
PURPOSE: To identify objective pre-treatment clinical parameters that could be used to predict for patients at high risk of requiring enteral tube feeding prior to head and neck radiotherapy. PATIENTS AND METHODS: A retrospective study was conducted on 160 consecutive patients attending for radiotherapy assessment. Regression analysis was used to determine various pre-treatment nutritional and tumour specific parameters associated with the use of enteral nutrition either before (prophylactic) or during (reactive) radiotherapy (RT). The significant parameters identified were then selected into categorical variables and compared between those who needed reactive enteral nutrition and the remainder of the group who did not. These results were used to generate predictive factors that could be used to identify those at high risk of malnutrition during RT for whom early or prophylactic enteral nutrition should be considered.
RESULTS: Fifty patients required enteral feeding of which 60% required this prior to radiotherapy. Multivariate analysis identified the following factors to be significant--body mass index, performance status (PS), advanced stage, pre-treatment weight loss, low serum albumin and protein, age, and smoking. The most significant categorical predictive parameters for reactive enteral feeding were stage 3-4 disease, PS 2-3, and smoking >20/day. The combination of these factors predicted a 75% chance of needing enteral nutrition.
CONCLUSION: Nutritional assessment is important prior to radiotherapy and is multifactorial. Using a combination of relatively simple and objective parameters, (performance status, smoking and disease stage) it is possible to identify those at high risk of needing enteral nutrition prior to starting RT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466819     DOI: 10.1016/j.radonc.2005.12.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  24 in total

1.  Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.

Authors:  Molly K Barnhart; Elizabeth C Ward; Bena Cartmill; Rachelle A Robinson; Virginia A Simms; Sophie J Chandler; Elea T Wurth; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-06       Impact factor: 2.503

2.  Smoking during radiotherapy for head and neck cancer and acute mucosal reaction.

Authors:  Beata Szeszko; Karolina Osowiecka; Monika Rucińska; Ewa Wasilewska-Teśluk; Krzysztof Gliński; Lucyna Kępka
Journal:  Rep Pract Oncol Radiother       Date:  2015-05-23

3.  Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Authors:  Alice Nourissat; Isabelle Bairati; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; François Meyer
Journal:  Support Care Cancer       Date:  2011-03-20       Impact factor: 3.603

4.  Nutritional interventions for cancer-induced cachexia.

Authors:  Norleena P Gullett; Vera C Mazurak; Gautam Hebbar; Thomas R Ziegler
Journal:  Curr Probl Cancer       Date:  2011 Mar-Apr       Impact factor: 3.187

5.  Prophylactic feeding tubes for patients with locally advanced head-and-neck cancer undergoing combined chemotherapy and radiotherapy-systematic review and recommendations for clinical practice.

Authors:  C Orphanidou; K Biggs; M E Johnston; J R Wright; A Bowman; S J Hotte; A Esau; C Myers; V Blunt; M Lafleur; B Sheehan; M A Griffin
Journal:  Curr Oncol       Date:  2011-08       Impact factor: 3.677

6.  Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.

Authors:  Belinda Vangelov; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-26       Impact factor: 2.503

7.  Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy.

Authors:  Ylva Tiblom Ehrsson; Per M Hellström; Kerstin Brismar; Lena Sharp; Ann Langius-Eklöf; Göran Laurell
Journal:  Support Care Cancer       Date:  2009-10-15       Impact factor: 3.603

Review 8.  Quality of life of oropharyngeal cancer patients treated with brachytherapy.

Authors:  David N Teguh; Peter C Levendag; Inger-Karine Kolkman-Deurloo; Peter van Rooij; Paul I M Schmitz
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

9.  The association between gastrostomy tube placement, poor post-operative outcomes, and hospital re-admissions in head and neck cancer patients.

Authors:  Ashley C Mays; Mitchell Worley; Feras Ackall; Ralph D'Agostino; Joshua D Waltonen
Journal:  Surg Oncol       Date:  2015-08-12       Impact factor: 3.279

10.  Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.

Authors:  Baoqing Li; Dan Li; Derick H Lau; D Gregory Farwell; Quang Luu; David M Rocke; Kathleen Newman; Jean Courquin; James A Purdy; Allen M Chen
Journal:  Radiat Oncol       Date:  2009-11-12       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.